对于葡萄糖载体1缺乏综合征的诊断和治疗建议
Mei-Jiao Zhang1, De Wu2, Li-Fei Yu3
1The First Hospital of Peking University, Beijing, China.
World journal of pediatrics : WJP
|January 2, 2025
概括
早期诊断葡萄糖载体1缺陷综合征 (Glut1DS) 是至关重要的. 快速的素饮食疗法显著改善了这种可治疗的神经代谢疾病的结果.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 遗传学 是一个遗传学.
背景情况:
- 葡萄糖载体1缺陷综合征 (Glut1DS) 是一种罕见的神经代谢疾病,由SLC2A1突变引起.
- 它具有广泛的临床症状,往往导致误诊和延迟治疗.
- 早期干预基因饮食治疗可以显著改善患者的预后.
研究的目的:
- 为诊断和治疗Glut1DS.DS制定基于证据的建议.
- 提高临床医生对这种罕见疾病的诊断意识.
- 为及时有效管理Glut1DS.提供系统指南.
主要方法:
- 召开了一个由28名代饮食治疗和Glut1DS管理专家组成的小组.
- 进行了广泛的文献审查和多次在线会议,讨论调查结果.
- 经过彻底的审议,最终的手稿被所有参与者批准.
主要成果:
- 暗示Glut1DS的主要临床表现包括发作,运动障碍和发育迟缓.
- 典型的表现包括带有运动障碍的发作,偶尔的眼睛和头部运动,以及运动诱导的松性动症.
- 基因检测和腰部穿刺是诊断的建议,而性饮食是主要治疗方法.
结论:
- 这些建议提供了一个系统的方法,用于快速识别,诊断和治疗Glut1DS.
- 及时诊断和启动性饮食治疗对于改善患者的治疗结果至关重要.
- 这些指南旨在减少误诊,并确保对这种可治疗的神经疾病的有效管理.
相关概念视频
Glucose Transporters
22.5K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
Glucose Absorption Into the Small Intestine
31.4K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.4K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications
516
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
516
Hypoglycemia and Glucagon
207
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
207


